NewcelX Strengthens Mazindol's Path with Major Publication and Strategic Advancements NewcelX Ltd. reinforces its position in the biopharmaceutical sector through a pivotal publication regarding Mazindol and its monetization strategies.

NewcelX Strengthens Mazindol's Path with Major Publication and Strategic Advancements #Switzerland #Zurich #Mazindol #NewCelX #Clinical_Drug_Investigation

Breakthrough Study Indicates Mazindol's Potential Against Opioid Addiction NLS Pharmaceutics reveals successful study results showcasing Mazindol's efficacy in reducing fentanyl-induced rewards in animal models, highlighting its non-opioid approach.

Breakthrough Study Indicates Mazindol's Potential Against Opioid Addiction #Switzerland #NLS_Pharmaceutics #Zurich #fentanyl #Mazindol